Follow us:

Northwest Voices

Seattle Times letters to the editor

October 27, 2014 at 7:05 AM

Ebola: Pharmaceutical companies need to find their soul

The Ebola epidemic has dominated the news since it broke out [“Nurse criticizes Ebola quarantine, raising concern,” Nation & World, Oct. 26]. Many questions are being asked, but one question not being asked is: “Where are the pharmaceutical companies?

Ebola is an unprofitable disease from the standpoint of the bottom line. Why develop a vaccine for a disease that mainly exists in poor countries? Also, where is the profit in developing any vaccine, since it is used only once or twice per person, as opposed to drugs for chronic diseases such as diabetes, heart disease or erectile dysfunction?

Haven’t we seen this before with HIV? It took years of advocacy and protest to drag the drug companies kicking and screaming into developing effective treatments for AIDS and HIV. Then it was like a miracle happened, and that particular plague was arrested, at least in developed countries.

No one is asking the drug companies to be totally altruistic and not make a good profit. They could do this by offsetting the research costs for inexpensive treatments by the highly profitable ones. Jesus said, “What does it profit a man if he gains the whole world and loses his soul?” Since corporations are now considered “people”, have the pharmaceutical companies lost their collective souls?

Sandy Renner, Seattle

Comments | More in Ebola | Topics: disease, Ebola, Pharmaceutical companies

COMMENTS

No personal attacks or insults, no hate speech, no profanity. Please keep the conversation civil and help us moderate this thread by reporting any abuse. See our Commenting FAQ.



The opinions expressed in reader comments are those of the author only, and do not reflect the opinions of The Seattle Times.


The Seattle Times

The door is closed, but it's not locked.

Take a minute to subscribe and continue to enjoy The Seattle Times for as little as 99 cents a week.

Subscription options ►

Already a subscriber?

We've got good news for you. Unlimited seattletimes.com content access is included with most subscriptions.

Subscriber login ►
The Seattle Times

To keep reading, you need a subscription upgrade.

We hope you have enjoyed your complimentary access. For unlimited seattletimes.com access, please upgrade your digital subscription.

Call customer service at 1.800.542.0820 for assistance with your upgrade or questions about your subscriber status.

The Seattle Times

To keep reading, you need a subscription.

We hope you have enjoyed your complimentary access. Subscribe now for unlimited access!

Subscription options ►

Already a subscriber?

We've got good news for you. Unlimited seattletimes.com content access is included with most subscriptions.

Activate Subscriber Account ►